📅 2026 Update: Key Developments in Mesothelioma Treatment

Since the original article was published, there have been significant advancements in the treatment of mesothelioma. New therapies and updated clinical guidelines are changing how patients are managed. The earlier article continues further down the page, providing foundational information on mesothelioma and related legal matters.

🧪 FDA Approvals for New Treatments

In September 2024, the FDA approved Keytruda® (pembrolizumab) for pleural mesothelioma. This approval allows it to be used alongside pemetrexed and platinum chemotherapy as a first-line treatment. The approval was based on a clinical trial that showed patients had a median overall survival of 17.3 months with this combination, compared to 16.1 months for those only receiving chemotherapy.

💊 New Combination Therapy Approval

In 2024, the FDA also approved the combination of Opdivo® (nivolumab) and Yervoy® (ipilimumab) for patients with inoperable malignant pleural mesothelioma. The CheckMate 743 trial demonstrated a median overall survival of 18.1 months for this combination, compared to 14.1 months with chemotherapy alone, marking a significant improvement in treatment options.

🏥 Updated Surgical Guidelines

The NCCN 2026 guidelines recommend pleurectomy/decortication (P/D) over extrapleural pneumonectomy (EPP) for pleural mesothelioma. EPP is now reserved for rare cases, and surgery is no longer considered a treatment option for stages 2 through 4 of pleural mesothelioma. This change reflects a shift toward less invasive procedures that may carry fewer risks.

💰 Updated Treatment Costs

As of October 2026, the average wholesale price (AWP) for Keytruda® is approximately $10,000 per 100 mg vial. For the combination of Opdivo® and Yervoy®, the costs are about $7,000 for Opdivo® and $1,200 for Yervoy® per respective dosing unit. The total treatment costs can vary based on specific patient needs and insurance plans.

📌 Key Takeaways

  • 🧪 Keytruda® approved as a first-line treatment for pleural mesothelioma.
  • 💊 Combination of Opdivo® and Yervoy® shows improved survival rates.
  • 🏥 Surgical guidelines favor pleurectomy/decortication over EPP.
  • 💰 Treatment costs for new therapies are significant and vary by patient.
  • 📅 Ongoing clinical trials remain essential for advancing treatment options.

💡 Tips for Understanding Mesothelioma Treatment Options

Review the specifics of your situation with your attorney.

🔍 Understand Treatment Eligibility

Eligibility for new treatments like Keytruda® and the Opdivo® and Yervoy® combination is determined by your oncologist. Typically, these options are available for patients with unresectable or inoperable malignant pleural mesothelioma who have not undergone prior systemic therapy.

🏥 Explore Clinical Trials

Clinical trials can offer access to cutting-edge treatments not yet widely available. Discuss with your healthcare provider to see if you qualify for any ongoing studies related to mesothelioma.

📅 Check Updated Guidelines

The NCCN guidelines are updated regularly. Staying informed about these changes can help you understand the most current recommendations for treatment and management of mesothelioma.

🧑‍⚕️ Discuss Multimodal Options

Combining different therapies, such as chemotherapy, surgery, and radiation, may enhance treatment effectiveness. Discuss the potential for multimodal therapy with your healthcare team.

🏷️ Know the Costs

Understanding the costs associated with new treatments is critical. Talk to your healthcare provider about your insurance coverage and any financial assistance programs that may be available.

📞 Reach Out for Support

Consider contacting organizations like the Mesothelioma Applied Research Foundation for support and resources. They can help you navigate treatment options and connect you with others facing similar challenges.

🏆 Free Options Ranked by User Reviews (2026)

No national paid services qualified based on user reviews in this area, so this section focuses on free government and nonprofit resources for mesothelioma support.

🥇 1. Mesothelioma Applied Research Foundation

This nonprofit organization provides vital resources and support for mesothelioma patients. They offer information on treatment options, access to clinical trials, and emotional support for patients and families.

🥈 2. National Cancer Institute (NCI)

The NCI delivers comprehensive information about mesothelioma, including treatment options and clinical trials. They also provide guides and contact information for patients who need assistance in navigating their treatment journey.

🥉 3. US Department of Veterans Affairs (VA)

The VA offers resources and benefits for veterans diagnosed with mesothelioma. They provide medical care, financial support, and access to specialized programs for veterans affected by asbestos exposure.

4️⃣ American Cancer Society (ACS)

The ACS provides a wealth of information on cancer treatments, including mesothelioma. They also offer support services, educational materials, and resources to help patients understand their diagnosis and treatment options.

5️⃣ Cancer Support Community

This nonprofit organization offers emotional and social support to cancer patients, including those with mesothelioma. They provide free support groups, online resources, and educational materials to help patients navigate their journey.

🔎 What to Check Before Paying for Help

  • 🕵️‍♂️ Verify the organization's credentials and reputation.
  • 📋 Review user feedback and ratings for services.
  • 💬 Ask about potential hidden fees or costs.
  • 📞 Ensure there is a clear communication line for support.
  • 🔍 Confirm that services offered align with your needs.

❓ Frequently Asked Questions

🤔 What are the new treatments available for mesothelioma?

Keytruda® and the combination of Opdivo® and Yervoy® have recently been approved as first-line treatments for advanced pleural mesothelioma.

🌐 How do I find clinical trials for mesothelioma?

Patients can consult with their healthcare providers to learn about ongoing clinical trials. Websites of organizations like the National Cancer Institute can also provide listings.

🏥 What are the risks associated with surgeries for mesothelioma?

Current guidelines recommend pleurectomy/decortication over extrapleural pneumonectomy due to lower associated risks. Discuss the potential risks and benefits with your healthcare team.

📊 How do these new treatments affect survival rates?

The recent approvals have shown improved median overall survival rates, with Keytruda® showing 17.3 months and the Opdivo® and Yervoy® combination showing 18.1 months.

⚖️ Are there any financial assistance programs for mesothelioma treatment?

Patients may find financial assistance through nonprofit organizations and government resources. It's important to inquire about available support during treatment planning.

🗓️ How often will I need to receive treatment?

For Keytruda®, patients typically receive intravenous infusions every three weeks. The Opdivo® and Yervoy® combination involves an initial induction phase followed by maintenance therapy, which may vary by patient.

⚖️ Recent Court Rulings on Mesothelioma Cases

Recent court rulings related to mesothelioma cases highlight ongoing legal issues surrounding asbestos exposure and patient rights. These rulings may impact future claims and treatment options for affected individuals.

You can browse more rulings on the news page to stay updated on recent legal developments.

End of October 2026 Update






Mesothelioma Treatment



 



 

Treatment


What is Mesothelioma?



 



 



Mesothelioma is a rare form of cancer that matures from the mutation of cells in the mesothelium—the protecting lining that serves as a shield for several internal organs of the body. 



 



 



Mesothelioma cancers are frequently caused by long-lasting exposure to asbestos. The majority of mesothelioma patients previously worked in jobs where they were in close contact with asbestos. 



Mesothelioma cancer typically forms in the outer lining of the lungs and the internal wall of the chest cavity. Symptoms associated with mesothelioma cancer include: shortness of breath (derived from a build-up of fluid between the lungs and the chest wall), substantial coughing and severe weight loss. 



 



 



Frequently, diagnosing mesothelioma cancer is particularly difficult. The complexities associated with diagnosis derive from the cancer’s slow-developing symptoms. In most cases, mesothelioma symptoms remain harmless for decades following the initial formation of the cancer. 



 



 



Similar to other cancer, mesothelioma is categorized by stage. As mesothelioma cancer progresses the outlook becomes dire for the patient. The insidious nature of mesothelioma is coupled with its inconspicuousness to create a very dangerous disease—the majority of mesothelioma patients die within one year of diagnosis. 



 



 



In most mesothelioma cases, the cancer will not be detected until the disease reaches its 3rd or 4th stage. When mesothelioma reaches advanced stages the disease becomes inoperable. That being said, there are still several mesothelioma treatment options which ultimately improve the patient’s quality of life.



 



 



Mesothelioma Treatment Options:



 



 



As stated above, diagnosing mesothelioma is extraordinarily difficult. And because mesothelioma cancer is highly malignant, patients and their loved ones typically have a difficult time addressing the issue of mesothelioma treatment. 



 



 



Nearly all mesothelioma patients have curative or palliative treatment options available. These mesothelioma treatment options will extend survival and increase quality of life by alleviating pain and mitigating the associated mesothelioma symptoms. 



 



 



Each mesothelioma case is considered unique. As such, there is no singular prescribed 



 



 



Radiation Therapy:



 



 



Mesothelioma is an infrequent and fatal cancer that develops from the mutating of cells in the mesothelium (protecting lining that covers several internal organs of the human body). Mesothelioma cancer is primarily caused by perpetual exposure to asbestos fibers. The majority of people who develop mesothelioma have previously worked in jobs where they are in close contact with asbestos. 



 



 



Mesothelioma commonly develops in the outer lining of the lungs and the internal wall of the chest cavity. Symptoms associated with the disease include: shortness of breath (due to a build-up of fluid between the lungs and the chest wall), heavy coughing and unexplained weight loss. 



 



 



In most cases, diagnosing mesothelioma is extremely difficult. The complexities associated with accurate diagnosis stem from the condition’s slow-developing symptoms. Often, mesothelioma symptoms will remain innocuous for decades following the initial development of the cancer. 



 



 



Similar to other medical conditions, mesothelioma is subcategorized into different stages. As mesothelioma cancer progresses the prognosis becomes dire. The insidiousness of mesothelioma cancer is met with its inconspicuousness to create a deadly cocktail—the majority of mesothelioma patients die within one year of diagnosis. 



 



 



Chemotherapy for Mesothelioma:



 



 



Patients diagnosed with Stage 4 Mesothelioma are in the last and most advanced portion of the cancer. Consequently, these patients have less mesothelioma treatment options; by the time mesothelioma cancer evolves into stage 4, symptoms and tumor growth drastically intensify when compared to previous stages. Stage 4 mesothelioma carries an extremely prognosis; however, mesothelioma treatment options are available to help patients cope with the severe pains. 



 



 



A stage 4 mesothelioma diagnosis is determined by the extent of how far the mesothelioma cancer has metastasized from its origin point. If the mesothelioma tumors, which initiated in the pleura, spread to the diaphragm, chest wall, lining of the heart or other areas, a stage 4 diagnoses will be rendered. Patients in the most advanced stage of mesothelioma cancer are deemed inoperable; invasive procedures, such as surgery, are avoided because of the substantial risks involved. 



 



 



Mesothelioma Symptoms: Stage 4 



 



 



Because Stage 4 mesothelioma impacts several parts of the human body, those suffering from the most-advanced form of mesothelioma cancer will invariably experience a number of symptoms in various locations throughout their body. Two of the more common mesothelioma symptoms associated with stage 4 include: severe chest pains and difficulty breathing. Sharp abdominal pains are also frequently associated with Stage 4 Mesothelioma, especially if the mesothelioma cancer has spread to the lower region of the abdomen. 



 



 



Mesothelioma Treatment Options: Stage 4 Mesothelioma



 



 



Stage 4 mesothelioma treatment options are palliative—they are only administered to mitigate the symptoms. For instance, Stage 4 mesothelioma treatment options are not curative; they are only administered to drain the excess fluids from the pleural cavity. As stated above, Stage 4 mesothelioma patients are not eligible to undergo surgeries, as their bodies are not physically able to withstand such aggressive procedures. If surgery, by chance, is administered on a stage 4 mesothelioma patient, it is only rendered to remove large tumors. This surgery aims to reduce pressure on the lungs and alleviate the attached symptoms. 



 



 



Because radiation therapy presents fewer side effects than chemotherapy or surgeries, it may be implemented to relieve stage 4 mesothelioma patients of their suffering. Some medical professionals will use a mix of palliative radiation therapy and minor surgery of large tumors to ease symptoms. This mesothelioma treatment option is undertaken to relieve symptoms and shrink tumors. Although none of these stage 4 mesothelioma treatment options do not cure the mesothelioma cancer, patients may elect to receive them to improve their quality of life. 



 



 



Mesothelioma Prognosis for Stage 4 Patients:



 



 



Patients stricken with Stage 4 mesothelioma have a poor prognosis. This pessimistic outlook is attached to stage 4 mesothelioma patients because the mesothelioma cancer has metastasized to other parts of the body. The widespread cancer limits the available mesothelioma treatment options. On average, stage 4 mesothelioma options have an average life expectancy of six and a half months after the diagnosis is made. 



Roughly 30% of people diagnosed with mesothelioma cancer receive diagnosis while in the 4th stage. If you are diagnosed with stage 4 mesothelioma you may be eligible to file a mesothelioma claim. These legal actions are undertaken by individuals who have contracted the disease due to negligence on part of an employer regarding asbestos exposure. Successful mesothelioma claims will provide compensation for the pain and suffering endured from the cancer.